Differences in Services Provided at Public and Nonprofit Hospitals Related to the 340B Drug Discount Program
JAMA Health Forum Conversations
Release Date: 05/03/2024
Changes in Policy and the Health of LGBTQ+ Populations
JAMA Health Forum Conversations
There is abundant evidence that sexual minority groups have worse health indicators than sexual majority groups. Gilbert Gonzales, PhD, MHA, of Vanderbilt University Medical Center joins JAMA Health Forum Editor in Chief Sandro Galea, MD,...
info_outline
The Centrality of Women’s Health to a Population Health Research Agenda
JAMA Health Forum Conversations
Both sex- and gender-based factors influence the health of women. A fully realized population health agenda needs to center women’s health as an area of conceptual and pragmatic focus. Rosa M Gonzalez-Guarda, PhD, MPH, RN, joins JAMA...
info_outline
National Policy to Support Better Mental Health in the US
JAMA Health Forum Conversations
About 1 in 5 adults in the US live with a mental health condition. In 2023, approximately 32% of US adults reported symptoms of depression and anxiety. Ruth Shim, MD, MPH, of the University of California, Davis, joins JAMA Health Forum...
info_outline
The Impact of Nonhealth Policies in a Time of Policy Disruption
JAMA Health Forum Conversations
The second Trump administration launched several actions in 2025 that directly affect the health of populations. Sara Bleich, PhD, of Harvard Chan School of Public Health joins JAMA Health Forum Editor in Chief Sandro Galea, MD, DrPH, to...
info_outline
The Evolution of Artificial Intelligence and Regulation
JAMA Health Forum Conversations
The evolution of artificial intelligence technology has outstripped most health policy oversight in the US. Michelle M. Mello, JD, PhD, Professor of Law and Professor of Health Policy at Stanford University, discusses this and more with...
info_outline
Improving Health and Health Care Affordability in the US with David Cutler
JAMA Health Forum Conversations
The US is an outlier in health system performance, spending more than other peer countries while performing worse. US economist David Cutler, who is the Otto Eckstein Professor of Applied Economics at Harvard University, discusses this and...
info_outline
The Threat to Health Insurance Coverage in the US
JAMA Health Forum Conversations
Increased health insurance coverage in the US has had a broad range of positive impacts on US health, including increases in preventive care and better chronic disease management. Larry Levitt, MPP, of the Henry J. Kaiser Family Foundation...
info_outline
The Potential Repercussions of Disinvestment in Health in the US
JAMA Health Forum Conversations
The first months of the Trump administration have been marked by a flurry of actions, many that have affected agencies directly related to health domestically and globally. Joshua M. Sharfstein, MD, of the Johns Hopkins Bloomberg School of...
info_outline
The US, the World Health Organization, and a New Era in Global Health
JAMA Health Forum Conversations
US withdrawal from the World Health Organization will have significant implications for global health. Lawrence Gostin, JD, JAMA Legal and Global Health Correspondent and Faculty Director of the O’Neill Institute for National and Global...
info_outline
What’s Next for JAMA Health Forum and for Health Policy?
JAMA Health Forum Conversations
Incoming Editor in Chief Sandro Galea, MD, DrPH, discusses the journal and the state of health policy with Deputy Editor Julie Donohue, PhD, and Senior Editor Melinda Buntin, PhD.
info_outlineJAMA Health Forum Editor John Ayanian, MD, MPP, speaks with Kelsey M. Owsley, PhD, of the University of Arkansas, and Sayeh Nikay, PhD, MPH, of the University of Minnesota, about how the 340B drug discount program influences the services offered by public and nonprofit hospitals. They also discuss new state policies and proposed federal policies to promote greater transparency and accountability in the 340B program.
Related Content: